ARPO
$1.30
Aerpio Pharmaceuticals
$.02
1.56%
ARPO
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  ($0.14)
Revenue:  $0.00 Mil
Thursday
Nov 5
8:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when ARPO reports earnings?
Beat
Meet
Miss

Where is ARPO's stock price going from here?
Up
Flat
Down
Stock chart of ARPO
Analysts
Summary of analysts' recommendations for ARPO
Score
Grade
Pivots
Resistance
$1.48
$1.42
$1.36

$1.31

Support
$1.24
$1.19
$1.13
Tweet
Growth
Description
Aerpio Pharmaceuticals Inc. is a biopharmaceutical company. It focuses on the development of novel therapeutics for vascular disorders with a concentration on diseases of the eye. The Company' product candidates include AKB?9778, ARP1536 and AKB-4924 which are in clinical stage. Aerpio Pharmaceuticals Inc. is based in Cincinnati, United States.